Case Western Reserve University and Atelerix Life Sciences Inc. have signed a two-year option to license a novel family of small molecules to prevent or reverse life-threatening opioid-related side effects.
RIVANNA® Announces Alliance With Tri-anim Health Services To Increase Nationwide Distribution Of Accuro®
Rivanna announced they have entered into a partnership with Tri-anim Health Services to represent and distribute the Accuro® portfolio of products in the United States.
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
HemoShear Therapeutics, Inc. has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc.
The University of Virginia School of Data Science on Tuesday announced a gift of $2 million from Capital One’s Center for Machine Learning.
BIO-CAT Microbials, LLC is pleased to announce receipt of a “Letter of No Objection” from the United States Food and Drug Administration.
Jason Sheehan, MD, PhD, Professor of Neurosurgery at the University of Virginia (UVA), has joined the Focused Ultrasound Foundation as a Senior Advisor for Brain Tumor Research.
Rivanna Launches Accuro Second Generation With BoneEnhance® Multi-Frequency Image Reconstruction And SpineNav3D™ AI-Based Spine Recognition
Rivanna announces the market introduction of Accuro Second Generation, combining innovative thoracic spine functionality with its groundbreaking introductory system.
HemoShear Therapeutics, Inc. has raised $40 million in funding that will enable the company to complete a phase 2 study of its lead compound.
Kevin Combs is now a vital part of the rise of CVille, the life science cluster within the BHCR that is blossoming in and around the University of Virginia (UVA).